Dantrolene - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:57:42Z

Switch SMW query from broadtable to table format for better layout with TOC

← Older revision		Revision as of 21:57, 20 March 2026
Line 55:		Line 55:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T17:25:22Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

← Older revision		Revision as of 17:25, 20 March 2026
Line 57:		Line 57:
	\|format=broadtable		\|format=broadtable
	\|headers=plain		\|headers=plain
	\|~~link~~=~~subject~~		\|mainlabel=-
	\|sort=Has Indication		\|sort=Has Indication
	\|limit=50		\|limit=50

Danbot: Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

2026-03-20T16:43:32Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

← Older revision		Revision as of 16:43, 20 March 2026
Line 44:		Line 44:
	==Comments==		==Comments==



			==Indications by Condition==
			''The following table is automatically generated from disease/condition pages across WikEM.''

			{{#ask:[[Has DrugName::Dantrolene]]
			\|?Has Indication=Indication
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|?Has Route=Route
			\|?Has Population=Population
			\|format=broadtable
			\|headers=plain
			\|link=subject
			\|sort=Has Indication
			\|limit=50
			}}

	==See Also==		==See Also==

ClaireLewis: /* References */

2019-09-20T23:49:57Z

References

← Older revision		Revision as of 23:49, 20 September 2019
Line 52:		Line 52:

	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:Toxicology]]

Mholtz at 18:40, 25 May 2017

2017-05-25T18:40:12Z

← Older revision		Revision as of 18:40, 25 May 2017
Line 3:		Line 3:
	*Dosage Forms:		*Dosage Forms:
	*Routes of Administration: IV, oral		*Routes of Administration: IV, oral
	*Common Trade Names:		*Common Trade Names: Dantrium

	==Adult Dosing==		==Adult Dosing==

ClaireLewis at 19:54, 24 May 2017

2017-05-24T19:54:30Z

← Older revision		Revision as of 19:54, 24 May 2017
Line 2:		Line 2:
	*Type: Skeletal muscle relaxant		*Type: Skeletal muscle relaxant
	*Dosage Forms:		*Dosage Forms:
	*Routes of Administration:		*Routes of Administration: IV, oral
	*Common Trade Names:		*Common Trade Names:

Line 11:		Line 11:

	==Pediatric Dosing==		==Pediatric Dosing==
			*Same as above

	==Special Populations==		==Special Populations==
	*[[Drug pregnancy categories\|Pregnancy Rating]]:		*[[Drug pregnancy categories\|Pregnancy Rating]]: C
	*Lactation risk:		*Lactation risk: Infant risk cannot be ruled out
	~~===~~Renal ~~Dosing===~~		*Renal dosing: no adjustment
	*Adult:		*Hepatic dosing: contraindicated in acute hepatitis or active cirrhosis
	*~~Pediatric:~~
	~~===~~Hepatic ~~Dosing===~~
	*Adult:
	*Pediatric:

	==Contraindications==		==Contraindications==
	*Allergy to class/drug		*Allergy to class/drug
			*Acute hepatitis or active cirrhosis

	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*~~hepatotoxicity~~		*Hepatotoxicity
			*GI bleed
			*Aplastic anemia, leukopenia, thrombocytopenia, small lymphocytic lymphoma
			*Muscle weakness, dysphagia, reduced vital capacity, dyspnea
	===Common===		===Common===
			*Flushing
			*Somnolence, fatigue, malaise
			*Nausea, diarrhea

	==Pharmacology==		==Pharmacology==
	*Half-life:		*Half-life: 10.8h
	*Metabolism:		*Metabolism: Hepatic
	*Excretion:		*Excretion:

	==Mechanism of Action==		==Mechanism of Action==
			*Interferes with release of calcium ions from sarcoplasmic reticulum in skeletal muscle, which results in dissociation of the excitation-contraction coupling

	==Comments==		==Comments==
Line 45:		Line 46:

	==See Also==		==See Also==
			*[[Neuroleptic malignant syndrome]]

	==References==		==References==

Rossdonaldson1: Created page with "==Administration== Type: Skeletal muscle relaxant Dosage Forms: Routes of Administration: Common Trade Names: ==Adult Dosing== ===Neuroleptic malignant syndrome=== *..."

2017-05-22T06:44:02Z

Created page with "==Administration== *Type: Skeletal muscle relaxant *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ===Neuroleptic malignant syndrome=== *..."

New page

==Administration==
*Type: Skeletal muscle relaxant
*Dosage Forms:
*Routes of Administration:
*Common Trade Names:

==Adult Dosing==
===[[Neuroleptic malignant syndrome]]===
*0.25-2mg/kg IV q6-12hr
*Max dose 10mg/kg/day

==Pediatric Dosing==

==Special Populations==
*[[Drug pregnancy categories|Pregnancy Rating]]:
*Lactation risk:
===Renal Dosing===
*Adult:
*Pediatric:
===Hepatic Dosing===
*Adult:
*Pediatric:

==Contraindications==
*Allergy to class/drug

==Adverse Reactions==
===Serious===
*hepatotoxicity

===Common===

==Pharmacology==
*Half-life:
*Metabolism:
*Excretion:

==Mechanism of Action==

==Comments==

==See Also==

==References==
<references/>

[[Category:Pharmacology]]